News Digest / Ticker: NERV

Ticker: NERV

08:04am, Tuesday, May 13, 2025

Minerva Neurosciences Reports Improved Losses Amid Ongoing Financial Challenges and FDA Compliance Efforts

Minerva Neurosciences, Inc. (NASDAQ: NERV) Overview As of March 31, 2025, Minerva Neurosciences, Inc. continues to operate as a clinical-stage biopharmaceutical company, focusing on developing proprietary product candidates aimed at treating central nervous system diseases. Despite recent regulat...